@callalloo I feel your post will mislead people if they do not read the article. The author concludes "For most patients with osteoporosis the benefits far exceed the risk of these two rare complications." The article also mentions that cancer patients taking larger doses are more likely to develop osteonecrosis. The risk of atypical fracture is higher after several years of use. Both are rare, as the doctor writes.

My doctor is giving me ONE dose of Reclast (with a trial of 20% usual dose due to sensitivity to meds) to "lock in" gains from Tymlos. There is no plan for long term use.

With my own painful and disabling spinal fractures, I encourage people to understand the risks of side effects versus possible benefits to health in a balanced way that brings health and well-being, whatever that path might be.

I am sorry for those with significant side effects. But fractures are life-changing too.